Glenmark Pharmaceuticals has informed that the company has enclosed press release, titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin Tablets, 5 mg and 10 mg’.
The above information is a part of company’s filings submitted to BSE.